MedPath

PRINTO (the Paediatric Rheumatology International Trials Organisation)

Conditions
Juvenile Idiopathic Arthritis
Registration Number
NCT00415935
Lead Sponsor
Institute of Child Health
Brief Summary

A comparison of outcome in children with JIA who are in remission on MTX, when MTX is then stopped for either 6 or 12 months

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  • Any child with JIA who has gone into remission using methotrexate
Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Rheumatology ICH

🇬🇧

London, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath